Corporate
Biotrial strengthens its partnership with Pareann Biotechnologies to expand Preclinical and Clinical capabilities
Already collaborating on the development of a novel preclinical lung cancer model combining a controlled microbiome, a humanized immune system, and tumor cells derived from patients (MESHCAP project), Biotrial…
Read more
